Compare INTZ & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INTZ | QNME |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Integrated Freight & Logistics |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1M | 14.1M |
| IPO Year | 2020 | 2024 |
| Metric | INTZ | QNME |
|---|---|---|
| Price | $0.41 | $0.31 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 173.6K | ★ 627.9K |
| Earning Date | 11-12-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.78 | 47.83 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $7,015,000.00 | $5,850,681.00 |
| Revenue This Year | $22.62 | N/A |
| Revenue Next Year | $26.44 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 21.56 | ★ 111.79 |
| 52 Week Low | $0.47 | $0.26 |
| 52 Week High | $1.56 | $1.40 |
| Indicator | INTZ | QNME |
|---|---|---|
| Relative Strength Index (RSI) | 34.65 | 37.85 |
| Support Level | N/A | $0.28 |
| Resistance Level | $0.89 | $0.43 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 3.15 | 10.24 |
Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.
Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.